Antibody purification is a cornerstone technique in biomedical research, diagnostic development, and early-stage therapeutic discovery. Whether you are working with hybridoma supernatant, mouse ascites fluid, or high-density CHO cell culture, extracting functional IgG in high purity requires a systematic, multi-step workflow. This guide walks you through each stage—from raw sample preparation to final quality control—providing actionable protocols, decision criteria, and cost-performance insights for research-scale antibody purification.
By the end of this article, you will have a complete framework for designing, executing, and optimizing an antibody purification workflow tailored to your specific application and scale requirements.
Before diving into specific steps, it helps to understand the landscape of antibody sources and the purity standards that drive your protocol choices.
The starting material for your purification workflow depends on your production system:
| Source |
Typical IgG Concentration |
Volume Range |
Notes |
| Hybridoma supernatant |
10–100 μg/mL |
100 mL – 10 L |
Low concentration; requires high-capacity capture resin |
| Mouse ascites fluid |
0.5–5 mg/mL |
1–10 mL per mouse |
High contamination; requires robust clarification |
| CHO/HEK293 cell culture |
0.5–5 g/L |
1–50 L (industrial); 100 mL – 1 L (research) |
High concentration; may skip capture concentration step |
Not every application demands pharmaceutical-grade purity. Matching your purification stringency to your downstream use saves time, reagents, and cost:
- Research applications (ELISA, Western blot, IHC): >90% purity is typically sufficient. A single Protein A capture step often meets this threshold.
- In vitro diagnostics: >95% purity recommended; polishing step may be beneficial to remove aggregates and host cell proteins (HCP).
- In vivo studies (animal models): >95% purity, with endotoxin testing mandatory. Aggregates must be minimized (<5%) to avoid nonspecific immune activation.
- Therapeutic development (early-stage RUO): >99% purity for characterization studies; aggregate content must be quantified and reported.
Understanding your purity target upfront dictates how many purification stages you need—and whether you can stop after capture or must proceed to polishing.
Clarification is the critical first step that removes cells, cell debris, lipids, and particulate matter from your biological sample. Skipping or underperforming this step leads to column clogging, backpressure spikes, and reduced resin lifetime in subsequent chromatography steps.
For volumes up to 500 mL, benchtop centrifugation is the most accessible clarification method:
- Speed: 3,000–10,000 × g
- Time: 10–20 minutes at 4°C
- Temperature: Keep samples cold (2–8°C) to minimize protease activity and IgG degradation
For larger volumes, use a floor-standing centrifuge with swinging-bucket rotors or continuous-flow centrifugation systems.
When processing volumes exceeding 1 liter, depth filtration becomes necessary. Depth filters (typically cellulose or glass fiber media with filter aid) capture particles throughout the filter matrix rather than on the surface alone, enabling higher throughput without rapid clogging.
- Typical pore ratings: 0.45–1.2 μm for pre-filtration; 0.22 μm for sterile filtration
- Advantage: Scalable from laboratory to manufacturing scale
- Tip: Apply depth filtration before, not after, sterile filtration to maximize filter lifetime
Final clarification to achieve cell-free supernatant uses a 0.22 μm membrane filter. This step is essential for:
- Protecting your chromatography column from microbial contamination
- Enabling aseptic handling throughout the downstream workflow
- Preparing samples for sterile storage
Use a pre-filter (0.45 μm) before the 0.22 μm filter to prevent rapid fouling of the final membrane.
If your sample will sit for more than 2–4 hours before purification, consider adding protease inhibitors to the clarified supernatant:
- AEBSF, PMSF: Serine protease inhibitors; broad specificity
- Leupeptin: Cysteine and serine protease inhibitor
- Aprotinin: Serine protease inhibitor; particularly useful for protecting IgG from proteolytic cleavage
Add inhibitors to your collection vessel during harvest rather than after clarification to maximize protection. Note that many protease inhibitors are toxic—handle with appropriate PPE and dispose properly.
Capture chromatography is the heart of your antibody purification workflow. This step concentrates your IgG from dilute solution and removes the majority of bulk contaminants (media proteins, HCP, DNA) in a single operation.
Protein A from Staphylococcus aureus binds the Fc region of IgG with high specificity and affinity (KD ≈ 10^-8 to 10^-9 M). Protein A chromatography is the gold standard for IgG capture because:
- High selectivity: >95% purity in a single step for many applications
- High capacity: Commercial resins offer 20–50 mg IgG per mL of resin
- Broad applicability: Works for human, rabbit, mouse, and pig IgG (with subclass variations)
Key considerations for Protein A:
| Property |
Impact |
| pH sensitivity |
Elution typically at pH 2.5–3.5; acid-sensitive antibodies may require optimization |
| Base stability |
Limited; standard Protein A is unstable in NaOH, limiting CIP options |
| Cost |
Historically expensive; newer alkali-stable variants (like MabCap At LX) reduce operational costs |
Protein G, from Group G Streptococcus, offers similar binding to Protein A but with important differences in species and subclass specificity:
- Weaker binding: Some human, rabbit, and cow IgG subclasses bind Protein G more strongly than Protein A
- Mouse IgG1: Binds Protein G but not Protein A—critical for many hybridoma workflows
- Albumin interference: Protein G has lower affinity for albumin, reducing competition in complex samples
Use Protein G when:
- Your antibody subclass has weak or no Protein A binding
- You need higher purity from mouse ascites or serum
- Working with antibodies that elute poorly from Protein A
Not every workflow requires a dedicated capture step. Consider skipping Protein A/G chromatography when:
- Your starting material is already concentrated (e.g., ascites fluid with 1–5 mg/mL IgG)
- You need only a quick enrichment rather than high purity (screening assays)
- Your antibody does not bind Protein A/G (use alternative resins like Protein L or mixed-mode ligands)
For research-scale workflows with concentrated samples, direct application to a polishing column may be sufficient—saving time and the cost of a capture step.
Polishing steps remove trace impurities that remain after capture chromatography: host cell proteins (HCP), DNA, leached Protein A/G ligand, aggregates, and charge variants. These steps are essential for applications requiring >95% purity or for antibodies intended for in vivo use.
Ion exchange chromatography (IEX) separates molecules based on surface charge differences:
- Cation exchange (CEX): Binds positively charged molecules at low pH; antibodies (pI ~6–9) bind well at pH below their pI. Elution achieved with increasing salt concentration.
- Anion exchange (AEX): Binds negatively charged molecules; typically run at pH above antibody pI, where the antibody carries a net negative charge and flows through while impurities (DNA, endotoxin, acidic HCP) bind.
When to use IEX:
- HCP removal after Protein A capture
- Removal of residual DNA and endotoxin
- Separation of charge variants (acidic/basic isoforms)
SEC, also called gel filtration, separates molecules by hydrodynamic radius. In antibody purification, SEC is primarily used for:
- Aggregate removal: Aggregated IgG elutes in the void volume (earlier), while monomeric IgG enters the pores and elutes later. Typical resolution: >95% aggregate removal in a single run.
- Desalting and buffer exchange: SEC separates proteins from salts, enabling buffer exchange without dialysis.
SEC limitations:
- Low loading capacity (typically <5% column volume per run)
- Slow flow rates; long run times
- Best suited for final polishing rather than bulk purification
HIC separates molecules based on surface hydrophobicity. High-salt conditions promote antibody binding to hydrophobic ligands; elution is achieved by decreasing salt concentration.
HIC advantages:
- Orthogonal to IEX and SEC; effective for removing impurities that co-purify with other modes
- Compatible with high-concentrate samples
- Good for aggregate removal in concentrated antibody preparations
When to use HIC:
- Removal of aggregates that co-elute with monomers in SEC
- Removal of hydrophobic impurities missed by other modes
- Polishing of concentrated antibody formulations
Not every workflow requires polishing chromatography. Add polishing steps when:
- Downstream application is in vivo: Aggregates and HCP can trigger immune responses or confound experimental results
- Antibody is aggregation-prone: Some antibodies form aggregates during storage or concentration; polishing removes these before they accumulate
- Regulatory documentation is required: For GLP/GCP studies, impurity profiles must be documented and controlled
- High-concentration formulations: Final polishing helps ensure stability and sterility of high-concentration IgG (>10 mg/mL)
After purification, your IgG is typically in a low-ionic-strength buffer (like the Protein A elution buffer at pH 2.5–3.5). Concentration and buffer exchange prepare your antibody for storage and downstream use.
Ultrafiltration uses semipermeable membranes to concentrate proteins while exchanging buffers through diafiltration:
- Spin concentrators (centrifugal): Ideal for 1–15 mL samples. Choose membrane MWCO 30–50 kDa (above IgG ~150 kDa to minimize retention).
- Tangential flow filtration (TFF): For volumes >50 mL. TFF systems (e.g., KrosFlo, Pellicon) offer faster processing and scalable throughput.
- Concentration factor: Aim for 10–50× concentration for typical storage (1–10 mg/mL).
Tips for ultrafiltration:
- Keep samples cold (2–8°C) during concentration to minimize aggregation
- Avoid excessive pressure and shear forces; ultraspeed can denature antibodies
- Rinse walls and membranes after concentration to recover maximally
Dialysis is a low-cost, gentle method for buffer exchange:
- Procedure: Place IgG solution in semipermeable membrane tubing (MWCO 12–14 kDa) and immerse in large volume of target buffer
- Volume ratio: 100–500× buffer volume for complete exchange
- Number of changes: 3–4 buffer changes over 4–24 hours
Advantages: No equipment required; minimal shear stress; inexpensive for small volumes.
Disadvantages: Slow; variable recovery; not practical for large volumes.
The right storage buffer stabilizes your antibody and prevents aggregation, degradation, and microbial growth:
| Buffer |
Composition |
Use Case |
Limitations |
| PBS, pH 7.4 |
137 mM NaCl, 2.7 mM KCl, 10 mM phosphate |
General storage; most common choice |
May not be optimal for all antibodies |
| PBS + 10% glycerol |
PBS + 10% v/v glycerol |
Cryopreservation; improves freeze-thaw stability |
Requires sterile filtration |
| PBS + 0.1% BSA |
PBS + 0.1% bovine serum albumin |
Long-term storage; prevents surface adsorption |
Not suitable for assays sensitive to BSA |
| Citrate buffer, pH 6.0 |
20 mM citrate |
Enhanced stability for some antibodies |
Acidic pH; check antibody compatibility |
Storage recommendations:
- Short-term (days to weeks): 2–8°C
- Long-term (months to years): -20°C (with glycerol) or -80°C (aliquoted, avoid freeze-thaw cycles)
- Concentration: 1–10 mg/mL is typical; higher concentrations may increase aggregation risk
Quality control is the final—and often overlooked—step in your antibody purification workflow. Rigorous QC ensures your antibody is functional, pure, and safe for its intended application.
SDS-PAGE remains the workhorse for purity assessment:
- Reducing conditions: Break disulfide bonds; shows heavy chain (~50 kDa) and light chain (~25 kDa) separately. Any extra bands indicate contamination.
- Non-reducing conditions: Disulfide bonds intact; detects aggregates (high molecular weight bands) and fragments (low molecular weight bands).
- Coomassie staining: Visualizes >0.1 μg per band; suitable for quick purity checks
- Silver staining: 10–100× more sensitive than Coomassie; detects trace impurities
CE-SDS offers quantitative, high-resolution analysis of antibody purity:
- Advantages over gel electrophoresis: Automated, high reproducibility, quantitative, minimal sample consumption
- Reducing CE-SDS: Separates by hydrodynamic radius; detects purity, heavy/light chain ratio, and fragments
- Non-reducing CE-SDS: Detects aggregates and half-antibodies
Size exclusion chromatography coupled with HPLC provides quantitative aggregate analysis:
- Monomer peak: Target; typically >95% for well-purified antibodies
- Aggregate peak: Elutes before monomer; should be <5% for in vivo applications
- Fragment peak: Elutes after monomer; indicates degradation
- Method: Isocratic flow; UV detection at 280 nm
The simplest method for IgG concentration:
- Procedure: Measure absorbance at 280 nm; apply Beer-Lambert law: C = A280 / (ε × path length)
- IgG extinction coefficient: ~1.35–1.5 mL·mg^-1·cm^-1 (varies by species and amino acid composition)
- Accuracy: ±5–10% depending on buffer composition; blank subtraction is essential
Bicinchoninic acid (BCA) assay is a colorimetric method for total protein quantification:
- Advantage: Less affected by buffer components (compatible with most salts, buffers, and detergents)
- Limitation: Measures all protein; does not confirm IgG-specific concentration
- Use: Cross-validate with A280; useful when buffer components interfere with spectrophotometry
Purity and concentration alone do not guarantee function. Activity assays verify that your antibody retains binding or functional activity after purification:
- ELISA (Enzyme-Linked Immunosorbent Assay): Direct or indirect antigen binding; quantitative endpoint
- SPR (Surface Plasmon Resonance, e.g., Biacore): Real-time kinetics; measures association (ka) and dissociation (kd) rate constants
- Flow cytometry: Binding to cell surface antigens; validates native conformation
- Functional assays: Neutralization, ADCC, complement activation—application-specific
As noted above, SEC-HPLC is the gold standard for quantitative aggregate analysis:
- Aggregate threshold: <5% for in vivo applications; <1% for therapeutic development
- Method validation: Ensure resolution of monomer from dimer and higher oligomers
DLS provides rapid aggregation screening:
- Particle size distribution: Detects aggregates and fragments in the 1 nm–1 μm range
- Polydispersity index (PDI): Lower PDI (<0.2) indicates monodisperse preparation
- Limitations: Less quantitative than SEC-HPLC; insensitive to trace aggregates
Endotoxin (lipopolysaccharide, LPS) from Gram-negative bacteria is a critical contaminant for antibodies used in animal studies:
- LAL (Limulus Amebocyte Lysate) assay: The standard endotoxin detection method; sensitivity to 0.005–0.1 EU/mL
- Pyrogen testing: Alternative to LAL; uses rabbit fever response
- Acceptance criteria: <5 EU/kg body weight per hour for systemic administration; stricter limits for CNS or intrathecal administration
- Prevention: Use endotoxin-free water, buffers, and reagents; depyrogenate glassware (250°C for 30 min); filter-sterilize all solutions
Endotoxin removal:
- Triton X-114 extraction: Detergent phase extraction removes LPS
- Polymyxin B columns: Binds and removes LPS
- Note: These methods may affect antibody recovery or activity; validate carefully
A well-designed antibody purification workflow requires more than just protocols—it requires the right equipment and consumables to maximize reproducibility, save time, and control costs.
The choice between prepacked and self-packed columns affects time, reproducibility, and cost:
| Factor |
Prepacked Columns |
Self-Packed Columns |
| Time |
Ready to use; no packing required |
30–60 minutes for packing and validation |
| Reproducibility |
Lot-to-lot consistency guaranteed by manufacturer |
Variable; depends on packing technique |
| Cost |
Higher per-unit cost; lower total cost of ownership |
Lower per-unit cost; higher labor cost |
| Scalability |
Limited to available formats |
Fully scalable; customize for any volume |
For research-scale workflows, prepacked columns from AHELIXBIOTECH offer a compelling balance: consistent performance, rapid setup, and significant cost savings versus market-leading alternatives.
Automated liquid handling systems standardize your antibody purification workflow:
- Cytiva ÄKTA Pure/Flex: Industry-standard FPLC; full software control, gradient elution, fraction collection
- Bio-Rad NGC Chromatography System: Versatile platform for research and process development
- Bio-Rad MiniPrep: Budget-friendly option for small-scale purifications
Key features to look for:
- UV/Vis monitoring (280 nm for protein, 260 nm for nucleic acids)
- Gradient capability (essential for IEX and HIC)
- Fraction collection (for peak-based collection)
- System scalability (should match your column format)
Modern FPLC systems enable end-to-end automation:
- Automated column equilibration and washing
- Gradient elution programming
- Peak-based fraction collection
- In-line buffer exchange via SEC
- Data logging for audit trails
Automation reduces hands-on time and improves reproducibility—critical when purifying multiple antibodies or running longitudinal studies.
Balancing performance and cost is essential for sustainable research operations:
- Choose the right column for the right scale: Do not use a 5 mL column for a 10 mL sample; match column volume to sample load (typically 5–10% column volume for IgG capture)
- Reuse resins wisely: Protein A/G resins degrade with use (IgG leakage, ligand oxidation); track performance over cycles and replace when capacity drops >20%
- Consider alkali-stable alternatives: Newer Protein A variants (e.g., MabCap At LX) tolerate 0.1–0.5 M NaOH CIP, extending resin lifetime and reducing contamination risk
For more in-depth guides on antibody purification techniques, explore these resources:
Building a reliable antibody purification workflow starts with selecting the right capture resin. MabCap At LX from AHELIXBIOTECH delivers high-capacity IgG capture with the durability you need for research-scale applications.
- Alkali-stable Protein A ligand: Withstands 0.1–0.5 M NaOH CIP for enhanced resin longevity and microbial control
- High binding capacity: >30 mg IgG per mL resin for efficient capture from dilute samples
- Prepacked convenience: Ready-to-use 1 mL and 5 mL columns eliminate packing time
- Proven performance: Validated for human, mouse, rabbit, and pig IgG across subclasses
| Product |
Price (1×1 mL) |
NaOH Stability |
Notes |
| AHELIXBIOTECH MabCap At LX |
$209 |
0.1–0.5 M NaOH |
37% less than MabSelect SuRe |
| Cytiva MabSelect SuRe |
$334 |
Limited |
Industry standard; higher cost |
| Sydlabs NMab |
$525 |
Moderate |
Premium pricing |
| Protein Ark HiFliQ |
~$190 |
Limited |
Comparable price; lower durability |
MabCap At LX at $209 per 1 mL column delivers 37% cost savings versus MabSelect SuRe ($334)—without sacrificing performance. For larger-scale workflows, bulk resin is also available.
Build a reliable antibody purification workflow with MabCap At LX — alkali-stable Protein A prepacked columns at $209/1×1mL (37% less than MabSelect SuRe). Available in 1mL and 5mL formats for any scale.
A robust antibody purification workflow requires careful planning at every stage: thorough clarification, high-capacity capture chromatography, targeted polishing, and rigorous quality control. By understanding the trade-offs at each step—and selecting the right tools for your scale and application—you can achieve consistent, high-purity IgG recovery while managing cost and time.
For your next antibody purification project, explore AHELIXBIOTECH's MabCap At LX prepacked columns and bulk resin options to streamline your workflow without breaking your budget.
Product Links:
AHELIXBIOTECH serves the global research community with high-quality affinity chromatography products for antibody purification. All products are for research use only (RUO).
